LARP1 and prostate carcinoma: Finally, as previously demonstrated in other cancer cell lines (Burrows et al., 2010; Hopkins et al., 2016; Tcherkezian et al., 2014), the ablation of LARP1 largely blocked cell proliferation in multiple cancer cell lines including prostate cancer cells (Figure 7—figure supplement 1B).